“…PEMFs enhance proliferation and differentiation of osteoblasts, stimulating anabolic bone proteins (Barnaba et al, ; Esmail et al, ; Li et al, ; Zhai et al, ), and this aspect has already been investigated in vivo (Fini et al, ; Benazzo et al, ; Veronesi, Cadossi et al, ). For such evidences, PEMFs are employed in clinical settings for improving bone fracture healing, treating delayed or non‐unions and stimulating osteointegration in primary arthroplasty or revision surgeries (Cebrián et al, ; Dallari et al, ; Massari, Caruso, Sollazzo, & Setti, ).However, until now, no literature studies have yet evaluated PEMFs stimulation on PBMCs exposed to UHMWPE for counteracting wear debris mediated osteclastogenesis. Some literature studies, without particle exposure, confirm that PEMFs stimulation reduces OC number and Nfatc1 expression in mice osteoclast‐like cells (He et al, ), in rat bone marrow cells (Chang, Hong‐Shong Chang, Wu, & Shih, ; Chang, Chang, Tsai, & Shih, ), or in RAW264.7 cells (Zhang et al, ) and increases OC apoptosis (Chen et al, ).…”